CG
FOMX

Cutler Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Cutler Group’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,900
Closed -$3K – 4941
2018
Q3 		$3K Buy
+7,900
New +$45.2K ﹤0.01% 3421

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Cutler Group's FOMX Position: Q1 2019 in Review

Cutler Group sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2019, closing a stake of 100 shares.

Cutler Group first reported a position in FOMX in Q4 2016 and held it in 5 quarters. The position peaked at $5K in Q1 2017. 62 funds tracked by Wall St. Rank hold FOMX as of Q1 2019.

  • Cutler Group reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 100 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2019.
  • Cutler Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2016 and held it in 5 quarters.
  • Cutler Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $5K in Q1 2017.
  • 62 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.